Recombinant Rat Steryl-sulfatase (Sts) is a protein enzyme that plays a crucial role in steroid metabolism. It is involved in the hydrolysis of sulfated steroids, converting them into their active forms. This enzyme is significant in various biological processes, including hormone regulation and metabolism. Recombinant versions of this enzyme are produced through genetic engineering techniques, allowing for its expression in various host systems such as mammalian cells, bacteria, or yeast.
Recombinant Rat Steryl-sulfatase (Sts) is typically produced with high purity, often exceeding 80% to 85% as determined by methods like SDS-PAGE . It can be formulated as a liquid or lyophilized powder, with storage conditions requiring refrigeration at 4°C for short-term use and freezing at -20°C to -80°C for long-term preservation . The enzyme is often tagged with a His-tag for easy purification and identification.
| Characteristic | Description |
|---|---|
| Species | Rat |
| Source | Mammalian Cells |
| Tag | His |
| Form | Liquid or Lyophilized Powder |
| Purity | >80% to >85% |
| Endotoxin | < 1.0 EU per μg |
| Storage Buffer | PBS Buffer |
Steryl-sulfatase is crucial in the metabolism of steroids, converting sulfated steroids into their active forms. This process is vital for hormone regulation and has implications in cancer research, particularly in the context of estrogen-dependent tumors. Inhibitors of steroid sulfatase have been explored for their potential in treating hormone-sensitive cancers by blocking the conversion of sulfated steroids to their active forms, thereby reducing tumor growth .
Steroid Metabolism: Recombinant Rat Steryl-sulfatase (Sts) is used in studies to understand steroid metabolism and its role in hormone regulation.
Cancer Research: Inhibitors of this enzyme have shown promise in blocking tumor growth by preventing the activation of sulfated steroids .
Enzyme Expression: The expression of Steryl-sulfatase can be influenced by various factors, including TNF-α, which has been shown to induce its expression in human cancer cells .
Recombinant Rat Steryl-sulfatase (Sts) is available from several biotechnology companies, with options for custom production based on specific requirements. The production process typically involves expression in mammalian cells, followed by purification and quality control measures to ensure high purity and low endotoxin levels .
| Aspect | Description |
|---|---|
| Host Systems | Mammalian Cells, E. coli, Yeast, Baculovirus |
| Purity Methods | SDS-PAGE |
| Customization | Available |
| Lead Time | 5-9 weeks |
This recombinant rat Steryl-sulfatase (Sts) catalyzes the conversion of sulfated steroid precursors, such as dehydroepiandrosterone sulfate (DHEA-S) and estrone sulfate, to their free steroid forms.
Rat Steryl-sulfatase (Sts), also known as Arylsulfatase C, Steroid sulfatase, or Steryl-sulfate sulfohydrolase, is a crucial enzyme involved in steroid metabolism. Its primary function is the conversion of sulfated steroid precursors to estrogens during pregnancy . This enzyme belongs to the sulfatase family and hydrolyzes several 3-beta-hydroxysteroid sulfates, which serve as metabolic precursors for estrogens, androgens, and cholesterol . The enzyme's activity is particularly significant in hormone-dependent processes and has been implicated in various physiological and pathological conditions. Rat Sts shares functional similarities with human STS, making it valuable for translational research in steroid metabolism disorders.
Rat Sts is a homodimeric enzyme with a molecular weight of approximately 65 kDa as observed in experimental analyses, although its calculated monomeric molecular weight is around 21.4 kDa . The protein is encoded by the STS gene, and its UniProt ID is P15589 . Structurally, Rat Sts is characterized as a multi-pass membrane protein with several membrane-spanning domains that anchor it to the microsomal and endoplasmic reticulum membranes . These transmembrane domains are crucial for its proper orientation and function within cellular compartments. The enzyme's active site contains catalytic residues essential for the hydrolysis of sulfate esters from steroid substrates.
Researchers have multiple methodological options for detecting and quantifying Rat Sts in biological samples:
ELISA-based detection: Highly sensitive sandwich ELISA kits are available for quantifying Rat Sts in serum, plasma, tissue homogenates, cell culture supernatants, and other biological fluids. These assays typically offer a detection range of 3.12-200 ng/mL with a sensitivity threshold of approximately 1.53 ng/mL . The intra-assay and inter-assay coefficient variations (CV) are typically around 4.3% and 7.2%, respectively, indicating good reproducibility .
Immunological methods: Anti-Steryl-sulfatase antibodies such as the Picoband® antibody can be used in multiple applications:
Western blotting: Detects Sts at approximately 65 kDa
Flow cytometry: For intracellular detection in fixed and permeabilized cells
Enzymatic activity assays: These measure the catalytic conversion of sulfated substrates. Researchers often use radioactive or fluorescent substrates to track the desulfation reaction catalyzed by Sts.
| Detection Method | Sensitivity | Sample Types | Applications |
|---|---|---|---|
| ELISA | 1.53 ng/mL | Serum, plasma, tissue homogenates, cell culture | Quantification of protein levels |
| Western blot | Moderate | Cell/tissue lysates | Protein expression and molecular weight confirmation |
| Flow cytometry | Variable | Fixed cells | Intracellular expression analysis |
| Enzymatic activity assay | Depends on substrate | Tissue preparations, recombinant protein | Functional analysis |
Successful expression and purification of recombinant Rat Sts requires careful consideration of its membrane-bound nature and structural complexity. Based on research protocols:
E. coli-based expression systems have been used for producing partial recombinant Rat Sts (e.g., position K297-E396), particularly for generating immunogens for antibody production
Mammalian expression systems (such as HEK293 or CHO cells) are preferable for full-length, properly folded Sts with post-translational modifications
Baculovirus-insect cell systems offer a compromise between bacterial and mammalian systems for membrane protein expression
Cell lysis using detergent-based buffers (commonly Triton X-100 or CHAPS) to solubilize membrane proteins
Affinity chromatography using tags (His, GST, or FLAG) fused to the recombinant protein
Size exclusion chromatography to separate the homodimeric form
Maintaining the presence of appropriate detergents throughout the purification process to prevent aggregation
Storage in buffers containing glycerol and reducing agents to maintain stability
The purified enzyme should be verified for activity using standard sulfatase activity assays to ensure that the recombinant protein maintains its native conformation and catalytic properties.
Measuring Rat Sts enzymatic activity in tissue samples requires consideration of the tissue-specific expression and potential interfering factors:
Fresh tissue samples should be homogenized in appropriate buffers (typically pH 7.4) containing protease inhibitors
Microsomal fractions can be isolated through differential centrifugation to enrich for Sts
Samples should be normalized for protein content before activity assays
Conversion assays: Measure the conversion of sulfated steroid precursors to estrogens, particularly during pregnancy states
Inhibition studies: Assess the reduction in activity after treatment with specific Sts inhibitors like STX213, which has been shown to inhibit rat liver STS activity by 99%
Comparative analysis: Monitor activity across different tissues to establish baseline differences in expression and function
When comparing Sts activity between normal and pathological states, it's critical to use consistent methodology, as variations in assay conditions can significantly impact results. For example, studies have shown that STS activity in malignant breast tissue is significantly higher than in normal tissue, correlating with disease progression .
When designing inhibition studies for Rat Sts, researchers should consider:
Compounds like STX213 have demonstrated potent inhibition (99% of rat liver STS activity) with minimal estrogenic effects
The duration of inhibition varies between compounds, with some (like STX213) showing activity for up to 12 days compared to others (like 667 COUMATE) that remain active for only 4 days
Oral dosing at 10 mg/kg per day for 5 days has been established as effective for certain inhibitors
Administration route affects bioavailability and tissue distribution
Differential binding affinities to erythrocyte carbonic anhydrase II
Variations in metabolism or breakdown rates
Liver STS activity as a primary indicator of systemic inhibition
Secondary hormone-dependent endpoints (such as uterine growth) to assess off-target estrogenic effects
Temporal dynamics of inhibition for determining optimal dosing schedules
Rat Sts plays a significant role in hormone-dependent disease models through its influence on steroid metabolism:
STS activity is elevated in various hormone-dependent cancers, making it relevant for rat models of these conditions
Elevated STS activity can increase local estrogen levels in tissues, potentially promoting tumor growth
STS mRNA expression has been identified as a predictor of recurrence in breast cancer patients, suggesting its value as a prognostic biomarker in rat models
Dysregulation of STS activity has been implicated in metabolic disorders, potentially through altered steroid hormone balance
Rat models with modulated Sts expression can help elucidate mechanisms behind metabolic syndrome components
Sts may influence neurosteroid levels that affect brain function, suggesting potential roles in neurodegenerative disease models
Researchers investigating these disease models should monitor both Sts expression levels and activity, as both parameters may provide different insights into disease progression and potential therapeutic interventions.
Several approaches can effectively modulate Rat Sts expression for functional studies:
CRISPR/Cas9 gene editing: For creating knockout or knock-in rat models with modified Sts
RNA interference: Using siRNA or shRNA to achieve temporary knockdown of Sts expression
Antisense oligonucleotides: For targeted reduction of Sts mRNA levels
Specific inhibitors: Compounds like STX213 have demonstrated effective inhibition of rat liver STS activity (99% inhibition) without estrogenic side effects
Substrate competition: Using sulfated compounds that compete with endogenous substrates
Allosteric modulators: Compounds that bind to non-catalytic sites and alter enzyme conformation
Western blotting with specific antibodies to confirm protein expression changes
Enzymatic activity assays to verify functional consequences
Downstream steroid hormone measurements to assess metabolic impact
Each approach offers different advantages in terms of specificity, duration of effect, and experimental context. Researchers should select methods based on their specific research questions and experimental constraints.
Studying Rat Sts provides valuable insights for translational research on human steroid metabolism disorders:
Rat Sts shares significant homology with human STS, making it a relevant model for studying conserved mechanisms
The subcellular localization to the endoplasmic reticulum membrane is consistent between rat and human STS
STS dysregulation has been implicated in human diseases including hormone-dependent cancers and X-linked ichthyosis (XLI)
Rat models with altered Sts expression or inhibition can mimic aspects of these conditions
Initial screening: Rat models provide platforms for initial screening of STS inhibitors
Efficacy validation: Assessment of compounds like STX213 in rat models helps predict human responses
Safety profiling: Rat studies help identify potential off-target effects before human trials
Researchers should note that despite similarities, species differences exist in steroid metabolism pathways. Therefore, findings in rat models should be validated with human samples or cell lines when possible before clinical translation.
Researchers face several technical challenges when detecting and measuring Rat Sts activity:
As a multi-pass membrane protein localized to the microsome and endoplasmic reticulum membranes , Sts can be difficult to extract while maintaining activity
Solution: Optimize detergent types and concentrations during sample preparation; consider using microsomal fractions rather than whole cell lysates
Other sulfatases may contribute to activity measurements
Solution: Use specific inhibitors as controls; validate with genetic knockdown models
Sts activity can degrade during storage or processing
Solution: Process samples quickly; standardize protocols with appropriate stabilizing agents
Low abundance in certain tissues may challenge detection
Solution: Use highly sensitive methods like ELISA (detection limit of 1.53 ng/mL) or amplified enzymatic assays
Lack of universal standards for activity reporting
Solution: Include well-characterized reference samples; report activity in multiple formats (e.g., both relative and absolute values)
When facing contradictory findings about Rat Sts function across different experimental models, researchers should consider:
Different detection methods (ELISA, Western blot, activity assays) may yield varying results
Solution: Use multiple complementary techniques to verify findings
Cell lines versus primary tissues may express different Sts isoforms or regulatory proteins
Solution: Characterize model systems thoroughly before making comparisons
Sts function may be influenced by hormonal status, age, sex, and other physiological factors
Solution: Document and control for biological variables; perform stratified analyses
Comparative validation: Verify findings across multiple models and methods
Mechanistic investigation: Explore molecular reasons for contradictions
Physiological relevance: Consider which model better reflects the in vivo situation
Integration approach: Develop synthesized hypotheses that accommodate seemingly contradictory findings
By systematically addressing these factors, researchers can better interpret contradictory findings and advance understanding of Sts biology.
Several emerging technologies offer promising advances for Rat Sts research:
Super-resolution microscopy for precise subcellular localization
Live-cell imaging with fluorescent activity-based probes to track Sts dynamics
Multi-omics approaches combining transcriptomics, proteomics, and metabolomics to understand Sts in steroid metabolic networks
Spatial transcriptomics to map Sts expression patterns in complex tissues
Cryo-electron microscopy for high-resolution structural analysis of membrane-bound Sts
Hydrogen-deuterium exchange mass spectrometry to study Sts conformational dynamics
Mathematical modeling of steroid metabolic pathways incorporating Sts activity data
Network analysis to identify novel regulatory mechanisms and interaction partners
Inducible and tissue-specific CRISPR systems for temporal and spatial control of Sts expression
Base editing technologies for creating specific Sts variants to study structure-function relationships
These technologies will enable researchers to address more sophisticated questions about Sts biology and potentially identify novel therapeutic targets related to steroid metabolism disorders.
Despite significant research on Rat Sts, several key questions remain unanswered:
What transcription factors and epigenetic mechanisms control tissue-specific Sts expression patterns?
How is Sts activity post-translationally regulated in different physiological states?
Which specific amino acid residues determine substrate specificity?
How does the homodimeric structure influence catalytic properties?
Does Sts play roles in non-classical steroid signaling pathways?
What is the significance of Sts in tissues where classical steroid action is minimal?
How do changes in Sts activity contribute to disease initiation versus progression?
Why does Sts activity increase in certain pathological conditions like cancer ?
What evolutionary adaptations in Sts explain species differences in steroid metabolism?
How conserved are Sts regulatory mechanisms across mammalian species?
Addressing these questions will require interdisciplinary approaches combining molecular biology, biochemistry, structural biology, and systems biology perspectives.